Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shriyansh Srivastava

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Medical Oncology (Northwood, London, England)|November 24, 2025
Microbial oncogenesis: the impact of Fusobacterium nucleatum on oral cancer pathwaysShriyansh Srivastava, Sachin Kumar
Environmental Toxicology|January 11, 2022
Platelet-rich plasma exhibits anti-inflammatory effect and attenuates cardiomyocyte damage by reducing NF-κB and enhancing VEGF expression in isoproterenol induced cardiotoxicity modelShubham Yadav, Shriyansh Srivastava, Gaaminepreet Singh
European Journal of Pharmacology|April 15, 2024
Single nucleotide polymorphism-based biomarker in primary hypertensionLaxmi, Pougang Golmei, Shriyansh Srivastava, et al.
Infectious Disorders Drug Targets|August 28, 2025
Avian Influenza A(H5N1) in Children: A Critical Public Health Alert Following the First Case in Victoria, AustraliaSharib Raza Khan, Shriyansh Srivastava, Sachin Kumar
Drug Development and Industrial Pharmacy|April 16, 2026
Systematic review on effectiveness of flavonoids against breast cancer: Insights from in-vitro, in-vivo studies and molecular pathway studiesDeepika Sharma, Ravindra Babu Malakapogu, Shriyansh Srivastava
Molecular Biology Reports|May 30, 2025
Precision exosome engineering for neurological therapeutics: molecular mechanisms and targeted strategiesDeepika Sharma, Shriyansh Srivastava, Malakapogu Ravindra Babu
Proteins|May 26, 2025
REV-ERBβ Binding Pocket Dynamics With Implications for Rational Design of Small Molecule ModulatorsShriyansh Srivastava, Vishnu A M, Rakesh Thakur, et al.
Expert Opinion on Therapeutic Targets|April 28, 2021
Inhibition of MK2 kinase as a potential therapeutic target to control neuroinflammation in Alzheimer's diseaseShriyansh Srivastava, Rohan Rajopadhye, Mangaldeep Dey, et al.
Chemico-Biological Interactions|March 20, 2022
Wnt/β-catenin antagonist pyrvinium rescues high dose isoproterenol induced cardiotoxicity in rats: Biochemical and immunohistological evidencesShriyansh Srivastava, Shubham Yadav, Gaaminepreet Singh, et al.
Biotechnology and Applied Biochemistry|August 21, 2025
Signal Amplification to Improve Electrochemical Biosensing for Infectious DiseasesAarti Gupta, Shriyansh Srivastava, Pougang Golmei, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Medical Oncology (Northwood, London, England)|November 24, 2025
Microbial oncogenesis: the impact of Fusobacterium nucleatum on oral cancer pathwaysShriyansh Srivastava, Sachin Kumar
Environmental Toxicology|January 11, 2022
Platelet-rich plasma exhibits anti-inflammatory effect and attenuates cardiomyocyte damage by reducing NF-κB and enhancing VEGF expression in isoproterenol induced cardiotoxicity modelShubham Yadav, Shriyansh Srivastava, Gaaminepreet Singh
European Journal of Pharmacology|April 15, 2024
Single nucleotide polymorphism-based biomarker in primary hypertensionLaxmi, Pougang Golmei, Shriyansh Srivastava, et al.
Infectious Disorders Drug Targets|August 28, 2025
Avian Influenza A(H5N1) in Children: A Critical Public Health Alert Following the First Case in Victoria, AustraliaSharib Raza Khan, Shriyansh Srivastava, Sachin Kumar
Drug Development and Industrial Pharmacy|April 16, 2026
Systematic review on effectiveness of flavonoids against breast cancer: Insights from in-vitro, in-vivo studies and molecular pathway studiesDeepika Sharma, Ravindra Babu Malakapogu, Shriyansh Srivastava
Molecular Biology Reports|May 30, 2025
Precision exosome engineering for neurological therapeutics: molecular mechanisms and targeted strategiesDeepika Sharma, Shriyansh Srivastava, Malakapogu Ravindra Babu
Proteins|May 26, 2025
REV-ERBβ Binding Pocket Dynamics With Implications for Rational Design of Small Molecule ModulatorsShriyansh Srivastava, Vishnu A M, Rakesh Thakur, et al.
Expert Opinion on Therapeutic Targets|April 28, 2021
Inhibition of MK2 kinase as a potential therapeutic target to control neuroinflammation in Alzheimer's diseaseShriyansh Srivastava, Rohan Rajopadhye, Mangaldeep Dey, et al.
Chemico-Biological Interactions|March 20, 2022
Wnt/β-catenin antagonist pyrvinium rescues high dose isoproterenol induced cardiotoxicity in rats: Biochemical and immunohistological evidencesShriyansh Srivastava, Shubham Yadav, Gaaminepreet Singh, et al.
Biotechnology and Applied Biochemistry|August 21, 2025
Signal Amplification to Improve Electrochemical Biosensing for Infectious DiseasesAarti Gupta, Shriyansh Srivastava, Pougang Golmei, et al.
Pageof 7